Zacks lowers Surgery Partners’ rating to ‘strong sell’: 3 quick notes

Zacks downgraded Surgery Partners shares from a “hold” to a “strong sell” Nov. 18, according to True Blue Tribune.

Advertisement

Here are three quick notes:

1. Bank of America recently reduced its price target on Surgery Partners’ shares from $23 to $19.

2. Surgery Partners has a P/E ratio of 55.67.

3. The company’s debt-to-equity ratio totals 1.56.

More articles on surgery centers:
Envision operates 263 ASCs, 1 surgical hospital as of Sept. 30 & more: 5 ASC company key notes
Stock market week-in-review for 4 large ASC chains — Nov. 13-17
Analysts cut Medical Facilities Corp.’s price target: 4 takeaways

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • In November, CMS finalized its Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule for 2026, which…

  • Outpatient imaging operator Lumexa Imaging Holdings’ recent debut on the Nasdaq Global Select Market spotlights growing investor interest in lower-cost…

Advertisement

Comments are closed.